| Salmon Pharma GmbH - Vafseo 450 mg, Filmtabletten | | 68862 | | 03 | | Vafseo 450 mg | | Filmtabletten | | B03XA08 | | Vadadustat | | 19.06.2023 | | |
| | Composition | | vadadustatum 450 mg, cellulosum microcristallinum, carboxymethylamylum natricum A, hypromellosum, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), E 171, macrogolum 3350, talcum, E 172 (rubrum), E 172 (nigrum), pro compresso obducto corresp. natrium 1.16 - 1.74 mg. | | Packungsbestandteile | | Comprimés filmés | | | | Principe actif | Concentr. |
|---|
| Vadadustatum | 450 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Nigrum) | | | | (Rubrum) | | | | Carboxymethylamylum Natricum A | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | E 172 | | color. | | Hypromellosum | | | | Macrogol | 3350 | | | Magnesii Stearas | | | | Poly(Alcohol Vinylicus) | | Überzug | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | | | Talcum | | |
|
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 005 | 28 | DDP | DDP | A | | Non | | 006 | 98 | DDP | DDP | A | | Non |
|
|
